{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:53:33Z","timestamp":1770458013150,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11739-020-02402-3","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T06:50:33Z","timestamp":1593672633000},"page":"1093-1104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Benefit of dual antithrombotic therapy with direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and metaanalysis of randomized clinical trials"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3740-9478","authenticated-orcid":false,"given":"Giacomo","family":"Zoppellaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe Maria","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Squizzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gentian","family":"Denas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Patti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"2402_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nrcardio.2016.114","volume":"13","author":"F Rahman","year":"2016","unstructured":"Rahman F, Kwan GF, Benjamin EJ (2016) Global epidemiology of atrial fibrillation. Nat Rev Cardiol 13:501","journal-title":"Nat Rev Cardiol"},{"key":"2402_CR2","doi-asserted-by":"publisher","first-page":"e24964","DOI":"10.1371\/journal.pone.0024964","volume":"6","author":"S Kralev","year":"2011","unstructured":"Kralev S, Schneider K, Lang S, Suselbeck T, Borggrefe M (2011) Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS ONE 6:e24964","journal-title":"PLoS ONE"},{"key":"2402_CR3","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","volume":"367","author":"S Connolly","year":"2006","unstructured":"Investigators AWGotA, Connolly S, Pogue J, Hart R, Pfeffer M et al (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367:1903\u20131912","journal-title":"Lancet"},{"key":"2402_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857\u2013867","journal-title":"Ann Intern Med"},{"key":"2402_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP et al (2019) 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J 40:87\u2013165","journal-title":"Eur Heart J"},{"key":"2402_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE et al (2019) 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 74:104\u2013132","journal-title":"J Am Coll Cardiol"},{"key":"2402_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","volume":"381","author":"WJ Dewilde","year":"2013","unstructured":"Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381:1107\u20131115","journal-title":"Lancet"},{"key":"2402_CR8","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","volume":"65","author":"KA Fiedler","year":"2015","unstructured":"Fiedler KA, Maeng M, Mehilli J, Schulz-Schupke S, Byrne RA et al (2015) Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial. J Am Coll Cardiol 65:1619\u20131629","journal-title":"J Am Coll Cardiol"},{"key":"2402_CR9","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","volume":"380","author":"RD Lopes","year":"2019","unstructured":"Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T et al (2019) Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 380:1509\u20131524","journal-title":"N Engl J Med"},{"key":"2402_CR10","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","volume":"377","author":"CP Cannon","year":"2017","unstructured":"Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377:1513\u20131524","journal-title":"N Engl J Med"},{"key":"2402_CR11","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","volume":"394","author":"P Vranckx","year":"2019","unstructured":"Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T et al (2019) Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet 394:1335\u20131343","journal-title":"Lancet"},{"key":"2402_CR12","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","volume":"375","author":"CM Gibson","year":"2016","unstructured":"Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW et al (2016) Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 375:2423\u20132434","journal-title":"N Engl J Med"},{"key":"2402_CR13","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1093\/eurheartj\/ehz732","volume":"40","author":"G Gargiulo","year":"2019","unstructured":"Gargiulo G, Goette A, Tijssen J, Eckardt L, Lewalter T et al (2019) Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. Eur Heart J 40:3757\u20133767","journal-title":"Eur Heart J"},{"issue":"4","key":"2402_CR14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/europace\/euz345","volume":"22","author":"M Galli","year":"2020","unstructured":"Galli M, Andreotti F, Porto I, Crea F (2020) Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention\/acute coronary syndrome patients. Europace 22(4):538\u2013546","journal-title":"Europace"},{"issue":"9","key":"2402_CR15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1161\/CIRCULATIONAHA.119.044584","volume":"141","author":"RD Lopes","year":"2019","unstructured":"Lopes RD, Leonardi S, Wojdyla DM, Vora AN, Thomas L et al (2019) Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the AUGUSTUS trial. Circulation 141(9):781\u2013783","journal-title":"Circulation"},{"key":"2402_CR16","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1161\/CIRCULATIONAHA.119.043308","volume":"140","author":"S Windecker","year":"2019","unstructured":"Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB et al (2019) Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing elective percutaneous coronary intervention: insights from the AUGUSTUS trial. Circulation 140:1921\u20131932","journal-title":"Circulation"},{"key":"2402_CR17","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/eurheartj\/ehz059","volume":"40","author":"J Oldgren","year":"2019","unstructured":"Oldgren J, Steg PG, Hohnloser SH, Lip GYH, Kimura T et al (2019) Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial. Eur Heart J 40:1553\u20131562","journal-title":"Eur Heart J"},{"key":"2402_CR18","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D et al (2011) The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"2402_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"2402_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12916-017-0875-8","volume":"15","author":"D Mendes","year":"2017","unstructured":"Mendes D, Alves C, Batel-Marques F (2017) Number needed to treat (NNT) in clinical literature: an appraisal. BMC Med 15:112","journal-title":"BMC Med"},{"key":"2402_CR21","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jama.2013.1556","volume":"309","author":"AK Chhatriwalla","year":"2013","unstructured":"Chhatriwalla AK, Amin AP, Kennedy KF, House JA, Cohen DJ et al (2013) Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. JAMA 309:1022\u20131029","journal-title":"JAMA"},{"key":"2402_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1517\/14740338.2015.1024222","volume":"14","author":"G Zoppellaro","year":"2015","unstructured":"Zoppellaro G, Granziera S, Padayattil Jose S, Denas G, Bracco A et al (2015) Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation. Expert Opin Drug Saf 14:683\u2013695","journal-title":"Expert Opin Drug Saf"},{"key":"2402_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijcard.2019.12.054","volume":"302","author":"G Ando","year":"2019","unstructured":"Ando G, Costa F (2019) Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials. Int J Cardiol 302:95\u2013102","journal-title":"Int J Cardiol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02402-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-020-02402-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02402-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T18:45:50Z","timestamp":1667241950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-020-02402-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2402"],"URL":"https:\/\/doi.org\/10.1007\/s11739-020-02402-3","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"14 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare the article has not been previously published elsewhere and is not under consideration for publication in another journal. All authors consent to the publication of the article in its actual form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patients were not directly involved in the study, data were obtained from published trials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"No informed consent is required for this type of study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}